Retro Rumors (40th Anniversary Episode) | TRC Healthcare Rumor vs Truth Podcast

🎉 *Special Anniversary Episode!* 🎉
Don and Steve throw it back to *1985* —complete with mullets 🦱, mustaches 🥸, and popped collars 👔—to celebrate *40 years of the Pharmacist’s Letter!*

🗂️ Join them as they dig into the archives and revisit some of the earliest (and wildest) claims ever published.

- Did we correctly predict the fate of rofecoxib and propoxyphene?
- Does topical benzoyl peroxide now cause cancer?
- Can you tell how long Don and Steve have been practicing pharmacy?

🕶️ Get ready for a blast from the past as we dig up some retro rumors!

🔍 They’ll reexamine research and insights into some interesting claims from yesteryear including:

- Whether *topical minoxidil* really works for hair regrowth (and why Steve looks like he joined the trial)
- The *Vioxx scandal* and how it reshaped FDA safety rules
- Why *Darvocet* disappeared from pharmacy shelves
- The truth about *benzoyl peroxide and cancer risk* (spoiler: it’s still safe!)
- How a drug from *lizard spit* became a blockbuster for weight loss.

_This episode is packed with nostalgia, clinical pearls, and a few good laughs._

TRC Healthcare Editor Hosts:

- *Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC*
- *Don Weinberger, PharmD, PMSP*

The clinical resources mentioned during the podcast are part of a subscription to *Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:*

- *Article:* See How Far We’ve Come in 40 Years: https://learning.therapeuticresearch.com/local/trc_custom/trc_url_resolver.php?path=/Content/Articles/PL/2025/Jun/See-How-Far-We-ve-Come-in-40-Years
- *Chart:* Treatment and Prevention of Hair Loss: https://learning.therapeuticresearch.com/local/trc_custom/trc_url_resolver.php?path=/Content/Segments/PRL/2011/Feb/Treatment-and-Prevention-of-Hair-Loss-11588
- *Chart:* Managing NSAID Risks: https://learning.therapeuticresearch.com/local/trc_custom/trc_url_resolver.php?path=/Content/Segments/PRL/2017/Jan/Managing-NSAID-Risks-10557
- *Algorithm:* Drug-Induced QT Prolongation: A Step-Wise Approach: https://learning.therapeuticresearch.com/local/trc_custom/trc_url_resolver.php?path=/Content/Segments/PRL/2016/Oct/Drug-Induced-QT-Prolongation-A-Stepwise-Approach-10260
- *Chart:* Pharmacotherapy of Acne: https://learning.therapeuticresearch.com/local/trc_custom/trc_url_resolver.php?path=/Content/Segments/PRL/2016/Feb/Pharmacotherapy-of-Acne-9453
- *Chart:* Comparison of GLP-1 and GIP/GLP-1 Receptor Agonists: https://learning.therapeuticresearch.com/local/trc_custom/trc_url_resolver.php?path=/Content/Segments/PRL/2017/Jan/Comparison-of-GLP-1-and-GIP-GLP-1-Receptor-Agonists-10594

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools:

- 🏷️Our listeners can get *10% off* a new subscription with code *podcast1025* at checkout. https://trchealthcare.com/shop/?trc_promo=podcast1025
- 🎓If you're a student, you can access a *free version* of Pharmacist’s Letter. https://login.therapeuticresearch.com/realms/trcSubscribers/protocol/openid-connect/registrations?client_id=ProfmanClient&response_type=code&scope=openid&code_challenge_method=S256&code_challenge=TLbI3CFp8snPD6CWEMGeBPhnjQBpQGNUxbqH3eJ-Asc&redirect_uri=https://account.therapeuticresearch.com/profile/account/new-student&response_mode=query&state=257d3831-d9bb-4863-8ec8-bb61b6914058&nonce=e216c68e-31cc-4c65-9144-ca806d84d5e1®_type=SPH
- 📌If you’re not yet a subscriber, find out more about our product offerings at *trchealthcare.com.*

Connect with us:

- 📱 Send us a *text:* https://www.buzzsprout.com/twilio/text_messages/2442382/open_sms
- 👍 *Follow, rate, and review* this show in your favorite podcast app.
- 📩 You can also reach out to provide feedback or make suggestions by emailing us at *ContactUs@trchealthcare.com.*

_The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment._

Rumor vs Truth is a production of TRC Healthcare.

00:00 - Introduction
00:20 - Welcome
01:46 - Claim (1985): Topical minoxidil is only approved for hair regrowth on the head, not hair loss maintenance.
04:52 - Claim (2002): Celecoxib (Celebrex) is safer than Rofecoxib (Vioxx).
07:45 - Claim (2005): Darvocet will be taken off the market.
09:49 - Claim (2006): Benzoyl peroxide causes cancer.
13:14 - Claim (2014): GLP-1 agonists (Byetta, etc.) are a good choice for weight loss in patients WITHOUT diabetes.
15:58 - Summary
16:56 - Audience Question
18:13 - A few more things...

Видео Retro Rumors (40th Anniversary Episode) | TRC Healthcare Rumor vs Truth Podcast канала TRC Healthcare